Renewal opportunity for ongoing NINDS-supported clinical trials needing more time and resources via U01 cooperative agreements.
Supports investigator-initiated, milestone-driven clinical trials requiring enhanced oversight for up to 7 years, with mechanistic studies as applicable and one trial per application.
Supports investigator-initiated clinical trials for neurological disorders, from early exploratory studies to Phase 3 confirmatory and comparative effectiveness trials.
This grant supports investigator-initiated clinical trials in arthritis, musculoskeletal, or skin diseases, funding both trial preparation and implementation for studies ready to begin.
Funding for ongoing dental and craniofacial clinical trials from NIDCR.
NIH plans a milestone-driven award supporting planning and early to definitive clinical trials across biomedical and other interventions for up to 7 years; applications are not yet being accepted.